Chris Bosh Latest News: Says He Did Not See Career Ending In Miami This Way; Clears NBA Profession Is Not Yet Over

Many have been expecting to see Chris Bosh play on the court again but it seems impossible as he was not cleared during his physical examination days ago leading to Miami Heat forcing him to end his NBA profession with them. He said in a recent interview that he did not expect to sever ties with Miami Heat but cleared that he believes his career is not yet over.

In an interview on Rebuilt on Uninterrupted.com, Sportsrageous reported that Bosh expressed his career in Miami Heat is over and done but there are 29 other teams he could go to. He noted that it is a whole league and one team's comment on whether he could play or not hopefully does not apply to other teams.

Bosh has been hoping to play this season after not being able to do so for two seasons now because of his blood clot. The comments of Bosh came after Miami Heat President Pat Riley said in a statement that the team is not working towards his return due to his health issues.

The NBA player added, "I didn't see my career in Miami ending like this. I didn't get a call or a text or anything like that. It's a business. We understand that." Bosh pointed out that if someone says certain things about a person, that person would not want to find things out via the media. He admitted that he was hurt regarding the comments of Riley, Slam reported.

Bosh continued to say that this is now his reality and it is up to him to make it a good or a bad thing. He noted that he can either complain or keep moving on and he decided to do the latter. Bosh is signed with the Miami Heat until the 2018-2019 NBA Season for $76 million. He reportedly will receive $4.7 million.

Miami Heat can try to remove Bosh from their salary cap by February next year and that will be the time that he will become a free agent. He can then seek out a team that will clear him medically so he could start playing again. He is reportedly using blood thinners now to resolve his blood clot issues.